Stemtech Corporation logo

Stemtech Corporation (STEK)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
14.62K Market Cap
- P/E Ratio
- Div Yield
10,000 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0.03
Want to track STEK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

STEK closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, STEK stock lost -87.5%.
STEK is not paying dividends to its shareholders.
The last earnings report, released on Jun 30, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0114%, based on the last three reports.
Stemtech Corporation has completed 1 stock splits, with the recent split occurring on Aug 05, 2021.
The company's stock is traded on one exchange.

STEK Chart

Stemtech Corporation / Viago and Eevia Health Announce Proposed RTO

Stemtech Corporation / Viago and Eevia Health Announce Proposed RTO

NAPLES, FL / ACCESSWIRE / December 5, 2024 / Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its planned merger ("Merger") with Seacret Direct, LLC ("VIÁGO") and now announces a proposal for a Reverse Takeover (RTO) of Eevia Health Plc ("Eevia"), a Finnish producer of bioactive organic Arctic plant extracts and nutraceuticals and has its common stock listed on the Swedish Spotlight Stock Market under the symbol "EEVIA". This strategic RTO marks a major milestone in the evolution of the combined companies, intending to create a vertically integrated health, wellness, and lifestyle entity that manufactures its own products and is positioned for significant growth in the global marketplace.

Accesswire | 1 year ago
Stemtech Corporation and Seacret Direct / Viago Execute Merger Agreement

Stemtech Corporation and Seacret Direct / Viago Execute Merger Agreement

NAPLES, FL / ACCESSWIRE / December 4, 2024 / Stemtech Corporation (OTCQB:STEK) is pleased to announce the merger agreement with Seacret Direct / VIÁGO, progressing their plan to establish a global leadership position in defining the future of lifestyle, health and longevity. The transaction will be completed through the issuance of 13 million preferred shares with a stated value of $2.50 per share.

Accesswire | 1 year ago
Stemtech Corporation and Viago Announce Strategic Merger

Stemtech Corporation and Viago Announce Strategic Merger

NAPLES, FL / ACCESSWIRE / November 20, 2024 / Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO) are pleased to announce they have reached an agreement in principle to merge their businesses. This merger represents a transformative step forward for both organizations, aiming to drive significant growth and enhance shareholder value.

Accesswire | 1 year ago

Stemtech Corporation (STEK) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Stemtech Corporation is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is STEK.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 14.62K.

Has Stemtech Corporation ever had a stock split?

Stemtech Corporation had 1 splits and the recent split was on Aug 05, 2021.

Stemtech Corporation Profile

Specialty Retail Industry
Consumer Discretionary Sector
Charles S. Arnold CEO
OTC PINK Exchange
85859W102 CUSIP
US Country
1 Employees
- Last Dividend
5 Aug 2021 Last Split
- IPO Date

Overview

Stemtech Corporation operates within the niche market of stem cell nutrition, focusing on the development of science-based products designed to enhance and support the body's stem cell processes. This American company, with a geographical reach that spans the Americas, Latin America, and Asia, leverages the potential of stem cells for maintaining optimal health. By developing dietary supplements that support the proliferation, circulation, and tissue migration of stem cells, Stemtech aims to facilitate the body's natural renewal processes. Based in Miramar, Florida, Stemtech stands at the forefront of utilizing stem cell nutrition to promote overall wellbeing.

Products and Services

  • RCM System

    A comprehensive dietary supplement regime designed to enhance the body’s natural stem cell functions, including their release, circulation, and tissue migration, thereby supporting the body's self-renewal capabilities.

  • stemrelease3

    An advanced formulation that specifically aids in the release of stem cells, ensuring a higher number of these vital cells are available to perform rejuvenating and repair functions throughout the body.

  • Stemflo

    This product focuses on improving the circulation of stem cells in the bloodstream, ensuring these cells can reach the areas of the body where they are most needed for repair and regeneration.

  • MigraStem

    MigraStem is designed to facilitate the efficient migration of stem cells to various tissues, enhancing the body’s natural repair and regeneration processes at the cellular level.

  • DermaStem

    Targets skin rejuvenation, utilizing stem cell nutrition to promote the natural renewal of skin cells, thereby improving skin texture and appearance for a healthier, more youthful look.

  • DermaStem Lift

    A specialized product within the DermaStem line, focused on lifting and firming the skin through enhanced stem cell activity, providing visible anti-aging benefits.

  • OraStem

    A unique oral care product that harnesses the power of stem cell nutrition to improve dental and gum health, promoting oral hygiene and overall wellness.

  • D-Fuze

    A dietary supplement designed to diffuse the stress factors affecting cellular health, thereby supporting the body’s overall wellbeing by ensuring stem cells can operate in an optimal environment.

Contact Information

Address: 4851 Tamiami Trail North
Phone: 954 715 6000